Salio, M., MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 9DS, United Kingdom; Awad, W., Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia, Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia; Veerapen, N., Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, United Kingdom; Gonzalez-Lopez, C., MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 9DS, United Kingdom; Kulicke, C., Division of Pulmonary and Critical Care Medicine, Department of Medicine, Oregon Health & Science University, Portland, OR 97239, United States, Research Department, Portland Veterans Administration Healthcare System, Portland, OR 97239, United States; Waithe, D., MRC Centre for Computational Biology, Wolfson Imaging Centre, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 9DS, United Kingdom; Martens, A.W.J., MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 9DS, United Kingdom; Lewinsohn, D.M., Division of Pulmonary and Critical Care Medicine, Department of Medicine, Oregon Health & Science University, Portland, OR 97239, United States, Research Department, Portland Veterans Administration Healthcare System, Portland, OR 97239, United States; Hobrath, J.V., Drug Discovery Unit, College of Life Sciences, University of Dundee, Dundee, DD1 5EH, United Kingdom; Cox, L.R., School of Chemistry, University of Birmingham, Birmingham, B15 2TT, United Kingdom; Rossjohn, J., Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia, Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia, Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, VIC 3800, Australia, Institute of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff, CF14 4XN, United Kingdom; Besra, G.S., Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, United Kingdom; Cerundolo, V., MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 9DS, United Kingdom
Recommended Citation:
Salio M.,Awad W.,Veerapen N.,et al. Ligand-dependent downregulation of MR1 cell surface expression[J]. Proceedings of the National Academy of Sciences of the United States of America,2020-01-01,117(19)